Guidelines and recommendations for French pharmaco-economic studies;Recommandations de bonnes pratiques des methodes d'evaluation economique des strategiques therapeutiques

Journal d'Economie Medicale

Volumn 16, Issue 4-5, 1998, Pages 329-372

  Auray, J P ^a   Bail, J N ^a   Beraud, C ^a   Beresniak, A ^a   Blachier, C ^a   Corcaud, S ^a   Fagnani, F ^a   Fiessinger, S ^a   Geneste, B ^a   Golinelli, D ^a   Lanoe, J L ^a   Launois, R ^a   Le Pen, C ^a   Lhoste, F ^a   Martelli, J ^a   Marty, C ^a   Lebrun, T ^a   Teisseire, B ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; COST MINIMIZATION ANALYSIS; COST UTILITY ANALYSIS; DECISION MAKING; FRANCE; PHARMACOECONOMICS; POLICY; QUALITY OF LIFE;

EID: 0032440621     PISSN: 02940736     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)